Literature DB >> 23102541

[National prostate cancer registry 2010 in Spain].

J M Cózar1, B Miñana, F Gómez-Veiga, A Rodríguez-Antolín, H Villavicencio, A Cantalapiedra, E Pedrosa.   

Abstract

OBJECTIVES: To estimate the 2010 incidence of PCa in Spain and describe the clinical profile of newly-diagnosed cases using a nationwide hospital-based registry.
MATERIAL AND METHODS: National epidemiological study in 25 public hospitals with a specific reference population according to the National Health System. Sociodemographic and clinical variables of all newly diagnosed, histopathological confirmed PCa cases were collected in 2010, in the area of influence of each centre. The age-standardised PCa incidence was determined based on the age distribution of the Spanish population in Spain and in 3 regions: Andalusia, Catalonia and Region of Madrid.
RESULTS: 4,087 new cases of PCa were diagnosed for a reference population of 4,933,940 men (21.8% of the Spanish male population). The estimated age-standardised PCa incidence was 82.27 cases per 100,000 men in Spain, 70,38 in Andalusia, 85,70 in Catalonia and 92,29 in the Region of Madrid. Mean age at diagnosis was 69 years. Median PSA was 8 ng/ml. Gleason score was ≤6 in 56.5%, 7 in 26.7% and >7 in 16.8% of patients. At diagnosis, 90% had localised disease.
CONCLUSIONS: In the 3 Regions analyzed, around 80-90% of the cases are diagnosed in a clinical localised stage. The incidence rates in Andalusía, Catalonia and Region of Madrid show a great difference between them due to several factors.
Copyright © 2012 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23102541     DOI: 10.1016/j.acuro.2012.06.006

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  4 in total

1.  Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.

Authors:  A Gómez Caamaño; A Zapatero; J López Torrecilla; X Maldonado
Journal:  Clin Transl Oncol       Date:  2015-11-30       Impact factor: 3.405

2.  Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.

Authors:  Xavier Bonfill; María José Martinez-Zapata; Robin W M Vernooij; María José Sánchez; María Morales Suárez-Varela; Javier de la Cruz; José Ignacio Emparanza; Montserrat Ferrer; José Ignacio Pijoán; Juan M Ramos-Goñi; Joan Palou; Stefanie Schmidt; Víctor Abraira; Javier Zamora
Journal:  BMC Urol       Date:  2015-07-02       Impact factor: 2.264

3.  The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry.

Authors:  Ángel Borque-Fernando; José Rubio-Briones; Luis Mariano Esteban; Argimiro Collado-Serra; Yoni Pallás-Costa; Pedro Ángel López-González; Jorge Huguet-Pérez; José Ignacio Sanz-Vélez; Jesús Manuel Gil-Fabra; Enrique Gómez-Gómez; Cristina Quicios-Dorado; Lluis Fumadó; Sara Martínez-Breijo; Juan Soto-Villalba
Journal:  Oncotarget       Date:  2017-10-24

4.  Social Support in Patients With Sexual Dysfunction After Non-Nerve-Sparing Radical Prostatectomy: A Qualitative Study.

Authors:  Cayetano Fernández-Sola; Álvaro Martínez-Bordajandi; Ana Patricia Puga-Mendoza; José Manuel Hernández-Padilla; Vinicius Jobim-Fischer; María Del Mar López-Rodríguez; José Granero-Molina
Journal:  Am J Mens Health       Date:  2020 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.